0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Molecules CDMO Services Market Research Report 2026
Published Date: 2026-01-29
|
Report Code: QYRE-Auto-24B18079
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Small Molecules CDMO Services Market Research Report 2024
BUY CHAPTERS

Global Small Molecules CDMO Services Market Research Report 2026

Code: QYRE-Auto-24B18079
Report
2026-01-29
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Small Molecules CDMO Services Market

The global Small Molecules CDMO Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Small Molecules CDMO (Small Molecule Contract Development and Manufacturing Organization) refers to a company that specializes in providing development and production services for small molecule drugs to pharmaceutical and biotech companies. Small molecule drugs generally refer to compounds with a smaller molecular weight, which are usually used to treat various diseases. CDMO provides a comprehensive service, including external third-party programs and their knowledge and development. As pharmacological substances become more and more complex, pharmaceutical companies face many problems in researching and manufacturing drug substances. More rapid research and production are needed to bring ideas to market faster, and many pharmaceutical companies prioritize cost control or cost reduction.
The North American market for Small Molecules CDMO Services is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Small Molecules CDMO Services is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Small Molecules CDMO Services in SME Pharmaceutical Company is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Small Molecules CDMO Services include Novartis, Thermo Fisher Scientific Inc, Pfizer, Lonza, Evonik, WuXi AppTec, Cambrex, Charles River Laboratories, Almac, Ajinomoto Bio, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Small Molecules CDMO Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Small Molecules CDMO Services. The Small Molecules CDMO Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Small Molecules CDMO Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Small Molecules CDMO Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Small Molecules CDMO Services Market Report

Report Metric Details
Report Name Small Molecules CDMO Services Market
Segment by Type
  • Oral Medications
  • Injectable Medications
  • Topical Medications
Segment by Application
  • SME Pharmaceutical Company
  • Large Pharmaceutical Company
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Thermo Fisher Scientific Inc, Pfizer, Lonza, Evonik, WuXi AppTec, Cambrex, Charles River Laboratories, Almac, Ajinomoto Bio, Porton, CordenPharma, Eurofins Scientific, 3xper Innoventure, Euroapi, Aragen, OncoBone Ltd, Aurigene Pharmaceutical Services Ltd, Onyx Scientific Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Small Molecules CDMO Services companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Small Molecules CDMO Services Market report?

Ans: The main players in the Small Molecules CDMO Services Market are Novartis, Thermo Fisher Scientific Inc, Pfizer, Lonza, Evonik, WuXi AppTec, Cambrex, Charles River Laboratories, Almac, Ajinomoto Bio, Porton, CordenPharma, Eurofins Scientific, 3xper Innoventure, Euroapi, Aragen, OncoBone Ltd, Aurigene Pharmaceutical Services Ltd, Onyx Scientific Limited

What are the Application segmentation covered in the Small Molecules CDMO Services Market report?

Ans: The Applications covered in the Small Molecules CDMO Services Market report are SME Pharmaceutical Company, Large Pharmaceutical Company

What are the Type segmentation covered in the Small Molecules CDMO Services Market report?

Ans: The Types covered in the Small Molecules CDMO Services Market report are Oral Medications, Injectable Medications, Topical Medications

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecules CDMO Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oral Medications
1.2.3 Injectable Medications
1.2.4 Topical Medications
1.3 Market by Application
1.3.1 Global Small Molecules CDMO Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 SME Pharmaceutical Company
1.3.3 Large Pharmaceutical Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecules CDMO Services Market Perspective (2021–2032)
2.2 Global Small Molecules CDMO Services Growth Trends by Region
2.2.1 Global Small Molecules CDMO Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Small Molecules CDMO Services Historic Market Size by Region (2021–2026)
2.2.3 Small Molecules CDMO Services Forecasted Market Size by Region (2027–2032)
2.3 Small Molecules CDMO Services Market Dynamics
2.3.1 Small Molecules CDMO Services Industry Trends
2.3.2 Small Molecules CDMO Services Market Drivers
2.3.3 Small Molecules CDMO Services Market Challenges
2.3.4 Small Molecules CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecules CDMO Services Players by Revenue
3.1.1 Global Top Small Molecules CDMO Services Players by Revenue (2021–2026)
3.1.2 Global Small Molecules CDMO Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Small Molecules CDMO Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Small Molecules CDMO Services Revenue
3.4 Global Small Molecules CDMO Services Market Concentration Ratio
3.4.1 Global Small Molecules CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecules CDMO Services Revenue in 2025
3.5 Global Key Players of Small Molecules CDMO Services Head Offices and Areas Served
3.6 Global Key Players of Small Molecules CDMO Services, Products and Applications
3.7 Global Key Players of Small Molecules CDMO Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Small Molecules CDMO Services Breakdown Data by Type
4.1 Global Small Molecules CDMO Services Historic Market Size by Type (2021–2026)
4.2 Global Small Molecules CDMO Services Forecasted Market Size by Type (2027–2032)
5 Small Molecules CDMO Services Breakdown Data by Application
5.1 Global Small Molecules CDMO Services Historic Market Size by Application (2021–2026)
5.2 Global Small Molecules CDMO Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Small Molecules CDMO Services Market Size (2021–2032)
6.2 North America Small Molecules CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Small Molecules CDMO Services Market Size by Country (2021–2026)
6.4 North America Small Molecules CDMO Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecules CDMO Services Market Size (2021–2032)
7.2 Europe Small Molecules CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Small Molecules CDMO Services Market Size by Country (2021–2026)
7.4 Europe Small Molecules CDMO Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Small Molecules CDMO Services Market Size (2021–2032)
8.2 Asia-Pacific Small Molecules CDMO Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Small Molecules CDMO Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Small Molecules CDMO Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Small Molecules CDMO Services Market Size (2021–2032)
9.2 Latin America Small Molecules CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Small Molecules CDMO Services Market Size by Country (2021–2026)
9.4 Latin America Small Molecules CDMO Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecules CDMO Services Market Size (2021–2032)
10.2 Middle East & Africa Small Molecules CDMO Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Small Molecules CDMO Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Small Molecules CDMO Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Small Molecules CDMO Services Introduction
11.1.4 Novartis Revenue in Small Molecules CDMO Services Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 Thermo Fisher Scientific Inc
11.2.1 Thermo Fisher Scientific Inc Company Details
11.2.2 Thermo Fisher Scientific Inc Business Overview
11.2.3 Thermo Fisher Scientific Inc Small Molecules CDMO Services Introduction
11.2.4 Thermo Fisher Scientific Inc Revenue in Small Molecules CDMO Services Business (2021–2026)
11.2.5 Thermo Fisher Scientific Inc Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Small Molecules CDMO Services Introduction
11.3.4 Pfizer Revenue in Small Molecules CDMO Services Business (2021–2026)
11.3.5 Pfizer Recent Development
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Small Molecules CDMO Services Introduction
11.4.4 Lonza Revenue in Small Molecules CDMO Services Business (2021–2026)
11.4.5 Lonza Recent Development
11.5 Evonik
11.5.1 Evonik Company Details
11.5.2 Evonik Business Overview
11.5.3 Evonik Small Molecules CDMO Services Introduction
11.5.4 Evonik Revenue in Small Molecules CDMO Services Business (2021–2026)
11.5.5 Evonik Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Small Molecules CDMO Services Introduction
11.6.4 WuXi AppTec Revenue in Small Molecules CDMO Services Business (2021–2026)
11.6.5 WuXi AppTec Recent Development
11.7 Cambrex
11.7.1 Cambrex Company Details
11.7.2 Cambrex Business Overview
11.7.3 Cambrex Small Molecules CDMO Services Introduction
11.7.4 Cambrex Revenue in Small Molecules CDMO Services Business (2021–2026)
11.7.5 Cambrex Recent Development
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Details
11.8.2 Charles River Laboratories Business Overview
11.8.3 Charles River Laboratories Small Molecules CDMO Services Introduction
11.8.4 Charles River Laboratories Revenue in Small Molecules CDMO Services Business (2021–2026)
11.8.5 Charles River Laboratories Recent Development
11.9 Almac
11.9.1 Almac Company Details
11.9.2 Almac Business Overview
11.9.3 Almac Small Molecules CDMO Services Introduction
11.9.4 Almac Revenue in Small Molecules CDMO Services Business (2021–2026)
11.9.5 Almac Recent Development
11.10 Ajinomoto Bio
11.10.1 Ajinomoto Bio Company Details
11.10.2 Ajinomoto Bio Business Overview
11.10.3 Ajinomoto Bio Small Molecules CDMO Services Introduction
11.10.4 Ajinomoto Bio Revenue in Small Molecules CDMO Services Business (2021–2026)
11.10.5 Ajinomoto Bio Recent Development
11.11 Porton
11.11.1 Porton Company Details
11.11.2 Porton Business Overview
11.11.3 Porton Small Molecules CDMO Services Introduction
11.11.4 Porton Revenue in Small Molecules CDMO Services Business (2021–2026)
11.11.5 Porton Recent Development
11.12 CordenPharma
11.12.1 CordenPharma Company Details
11.12.2 CordenPharma Business Overview
11.12.3 CordenPharma Small Molecules CDMO Services Introduction
11.12.4 CordenPharma Revenue in Small Molecules CDMO Services Business (2021–2026)
11.12.5 CordenPharma Recent Development
11.13 Eurofins Scientific
11.13.1 Eurofins Scientific Company Details
11.13.2 Eurofins Scientific Business Overview
11.13.3 Eurofins Scientific Small Molecules CDMO Services Introduction
11.13.4 Eurofins Scientific Revenue in Small Molecules CDMO Services Business (2021–2026)
11.13.5 Eurofins Scientific Recent Development
11.14 3xper Innoventure
11.14.1 3xper Innoventure Company Details
11.14.2 3xper Innoventure Business Overview
11.14.3 3xper Innoventure Small Molecules CDMO Services Introduction
11.14.4 3xper Innoventure Revenue in Small Molecules CDMO Services Business (2021–2026)
11.14.5 3xper Innoventure Recent Development
11.15 Euroapi
11.15.1 Euroapi Company Details
11.15.2 Euroapi Business Overview
11.15.3 Euroapi Small Molecules CDMO Services Introduction
11.15.4 Euroapi Revenue in Small Molecules CDMO Services Business (2021–2026)
11.15.5 Euroapi Recent Development
11.16 Aragen
11.16.1 Aragen Company Details
11.16.2 Aragen Business Overview
11.16.3 Aragen Small Molecules CDMO Services Introduction
11.16.4 Aragen Revenue in Small Molecules CDMO Services Business (2021–2026)
11.16.5 Aragen Recent Development
11.17 OncoBone Ltd
11.17.1 OncoBone Ltd Company Details
11.17.2 OncoBone Ltd Business Overview
11.17.3 OncoBone Ltd Small Molecules CDMO Services Introduction
11.17.4 OncoBone Ltd Revenue in Small Molecules CDMO Services Business (2021–2026)
11.17.5 OncoBone Ltd Recent Development
11.18 Aurigene Pharmaceutical Services Ltd
11.18.1 Aurigene Pharmaceutical Services Ltd Company Details
11.18.2 Aurigene Pharmaceutical Services Ltd Business Overview
11.18.3 Aurigene Pharmaceutical Services Ltd Small Molecules CDMO Services Introduction
11.18.4 Aurigene Pharmaceutical Services Ltd Revenue in Small Molecules CDMO Services Business (2021–2026)
11.18.5 Aurigene Pharmaceutical Services Ltd Recent Development
11.19 Onyx Scientific Limited
11.19.1 Onyx Scientific Limited Company Details
11.19.2 Onyx Scientific Limited Business Overview
11.19.3 Onyx Scientific Limited Small Molecules CDMO Services Introduction
11.19.4 Onyx Scientific Limited Revenue in Small Molecules CDMO Services Business (2021–2026)
11.19.5 Onyx Scientific Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Small Molecules CDMO Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Oral Medications
 Table 3. Key Players of Injectable Medications
 Table 4. Key Players of Topical Medications
 Table 5. Global Small Molecules CDMO Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Small Molecules CDMO Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Small Molecules CDMO Services Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Small Molecules CDMO Services Market Share by Region (2021–2026)
 Table 9. Global Small Molecules CDMO Services Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Small Molecules CDMO Services Market Share by Region (2027–2032)
 Table 11. Small Molecules CDMO Services Market Trends
 Table 12. Small Molecules CDMO Services Market Drivers
 Table 13. Small Molecules CDMO Services Market Challenges
 Table 14. Small Molecules CDMO Services Market Restraints
 Table 15. Global Small Molecules CDMO Services Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Small Molecules CDMO Services Market Share by Players (2021–2026)
 Table 17. Global Top Small Molecules CDMO Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Small Molecules CDMO Services Revenue, 2025
 Table 18. Ranking of Global Top Small Molecules CDMO Services Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Small Molecules CDMO Services Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Small Molecules CDMO Services, Headquarters and Area Served
 Table 21. Global Key Players of Small Molecules CDMO Services, Products and Applications
 Table 22. Global Key Players of Small Molecules CDMO Services, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Small Molecules CDMO Services Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Small Molecules CDMO Services Revenue Market Share by Type (2021–2026)
 Table 26. Global Small Molecules CDMO Services Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Small Molecules CDMO Services Revenue Market Share by Type (2027–2032)
 Table 28. Global Small Molecules CDMO Services Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Small Molecules CDMO Services Revenue Market Share by Application (2021–2026)
 Table 30. Global Small Molecules CDMO Services Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Small Molecules CDMO Services Revenue Market Share by Application (2027–2032)
 Table 32. North America Small Molecules CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Small Molecules CDMO Services Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Small Molecules CDMO Services Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Small Molecules CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Small Molecules CDMO Services Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Small Molecules CDMO Services Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Small Molecules CDMO Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Small Molecules CDMO Services Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Small Molecules CDMO Services Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Small Molecules CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Small Molecules CDMO Services Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Small Molecules CDMO Services Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Small Molecules CDMO Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Small Molecules CDMO Services Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Small Molecules CDMO Services Market Size by Country (US$ Million), 2027–2032
 Table 47. Novartis Company Details
 Table 48. Novartis Business Overview
 Table 49. Novartis Small Molecules CDMO Services Product
 Table 50. Novartis Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 51. Novartis Recent Development
 Table 52. Thermo Fisher Scientific Inc Company Details
 Table 53. Thermo Fisher Scientific Inc Business Overview
 Table 54. Thermo Fisher Scientific Inc Small Molecules CDMO Services Product
 Table 55. Thermo Fisher Scientific Inc Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 56. Thermo Fisher Scientific Inc Recent Development
 Table 57. Pfizer Company Details
 Table 58. Pfizer Business Overview
 Table 59. Pfizer Small Molecules CDMO Services Product
 Table 60. Pfizer Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 61. Pfizer Recent Development
 Table 62. Lonza Company Details
 Table 63. Lonza Business Overview
 Table 64. Lonza Small Molecules CDMO Services Product
 Table 65. Lonza Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 66. Lonza Recent Development
 Table 67. Evonik Company Details
 Table 68. Evonik Business Overview
 Table 69. Evonik Small Molecules CDMO Services Product
 Table 70. Evonik Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 71. Evonik Recent Development
 Table 72. WuXi AppTec Company Details
 Table 73. WuXi AppTec Business Overview
 Table 74. WuXi AppTec Small Molecules CDMO Services Product
 Table 75. WuXi AppTec Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 76. WuXi AppTec Recent Development
 Table 77. Cambrex Company Details
 Table 78. Cambrex Business Overview
 Table 79. Cambrex Small Molecules CDMO Services Product
 Table 80. Cambrex Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 81. Cambrex Recent Development
 Table 82. Charles River Laboratories Company Details
 Table 83. Charles River Laboratories Business Overview
 Table 84. Charles River Laboratories Small Molecules CDMO Services Product
 Table 85. Charles River Laboratories Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 86. Charles River Laboratories Recent Development
 Table 87. Almac Company Details
 Table 88. Almac Business Overview
 Table 89. Almac Small Molecules CDMO Services Product
 Table 90. Almac Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 91. Almac Recent Development
 Table 92. Ajinomoto Bio Company Details
 Table 93. Ajinomoto Bio Business Overview
 Table 94. Ajinomoto Bio Small Molecules CDMO Services Product
 Table 95. Ajinomoto Bio Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 96. Ajinomoto Bio Recent Development
 Table 97. Porton Company Details
 Table 98. Porton Business Overview
 Table 99. Porton Small Molecules CDMO Services Product
 Table 100. Porton Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 101. Porton Recent Development
 Table 102. CordenPharma Company Details
 Table 103. CordenPharma Business Overview
 Table 104. CordenPharma Small Molecules CDMO Services Product
 Table 105. CordenPharma Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 106. CordenPharma Recent Development
 Table 107. Eurofins Scientific Company Details
 Table 108. Eurofins Scientific Business Overview
 Table 109. Eurofins Scientific Small Molecules CDMO Services Product
 Table 110. Eurofins Scientific Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 111. Eurofins Scientific Recent Development
 Table 112. 3xper Innoventure Company Details
 Table 113. 3xper Innoventure Business Overview
 Table 114. 3xper Innoventure Small Molecules CDMO Services Product
 Table 115. 3xper Innoventure Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 116. 3xper Innoventure Recent Development
 Table 117. Euroapi Company Details
 Table 118. Euroapi Business Overview
 Table 119. Euroapi Small Molecules CDMO Services Product
 Table 120. Euroapi Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 121. Euroapi Recent Development
 Table 122. Aragen Company Details
 Table 123. Aragen Business Overview
 Table 124. Aragen Small Molecules CDMO Services Product
 Table 125. Aragen Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 126. Aragen Recent Development
 Table 127. OncoBone Ltd Company Details
 Table 128. OncoBone Ltd Business Overview
 Table 129. OncoBone Ltd Small Molecules CDMO Services Product
 Table 130. OncoBone Ltd Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 131. OncoBone Ltd Recent Development
 Table 132. Aurigene Pharmaceutical Services Ltd Company Details
 Table 133. Aurigene Pharmaceutical Services Ltd Business Overview
 Table 134. Aurigene Pharmaceutical Services Ltd Small Molecules CDMO Services Product
 Table 135. Aurigene Pharmaceutical Services Ltd Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 136. Aurigene Pharmaceutical Services Ltd Recent Development
 Table 137. Onyx Scientific Limited Company Details
 Table 138. Onyx Scientific Limited Business Overview
 Table 139. Onyx Scientific Limited Small Molecules CDMO Services Product
 Table 140. Onyx Scientific Limited Revenue in Small Molecules CDMO Services Business (US$ Million), 2021–2026
 Table 141. Onyx Scientific Limited Recent Development
 Table 142. Research Programs/Design for This Report
 Table 143. Key Data Information from Secondary Sources
 Table 144. Key Data Information from Primary Sources
 Table 145. Authors List of This Report


List of Figures
 Figure 1. Small Molecules CDMO Services Picture
 Figure 2. Global Small Molecules CDMO Services Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Small Molecules CDMO Services Market Share by Type: 2025 vs 2032
 Figure 4. Oral Medications Features
 Figure 5. Injectable Medications Features
 Figure 6. Topical Medications Features
 Figure 7. Global Small Molecules CDMO Services Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Small Molecules CDMO Services Market Share by Application: 2025 vs 2032
 Figure 9. SME Pharmaceutical Company Case Studies
 Figure 10. Large Pharmaceutical Company Case Studies
 Figure 11. Small Molecules CDMO Services Report Years Considered
 Figure 12. Global Small Molecules CDMO Services Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Small Molecules CDMO Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Small Molecules CDMO Services Market Share by Region: 2025 vs 2032
 Figure 15. Global Small Molecules CDMO Services Market Share by Players in 2025
 Figure 16. Global Small Molecules CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Small Molecules CDMO Services Revenue in 2025
 Figure 18. North America Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Small Molecules CDMO Services Market Share by Country (2021–2032)
 Figure 20. United States Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Small Molecules CDMO Services Market Share by Country (2021–2032)
 Figure 24. Germany Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Small Molecules CDMO Services Market Share by Region (2021–2032)
 Figure 32. China Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Small Molecules CDMO Services Market Share by Country (2021–2032)
 Figure 40. Mexico Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Small Molecules CDMO Services Market Share by Country (2021–2032)
 Figure 44. Israel Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Small Molecules CDMO Services Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Novartis Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 48. Thermo Fisher Scientific Inc Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 49. Pfizer Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 50. Lonza Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 51. Evonik Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 52. WuXi AppTec Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 53. Cambrex Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 54. Charles River Laboratories Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 55. Almac Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 56. Ajinomoto Bio Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 57. Porton Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 58. CordenPharma Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 59. Eurofins Scientific Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 60. 3xper Innoventure Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 61. Euroapi Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 62. Aragen Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 63. OncoBone Ltd Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 64. Aurigene Pharmaceutical Services Ltd Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 65. Onyx Scientific Limited Revenue Growth Rate in Small Molecules CDMO Services Business (2021–2026)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc